Portfolio (Quarterly)
Guide ↗
Atlas Venture Life Science Advisors, LLC
· CIK 0001917529| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 4,659,874.0 | $362.6M | 41.91% | NEW | — | $77.81 | +2.4% |
| 2 | DYN | Dyne Therapeutics, Inc. | Healthcare | 9,130,465.0 | $178.6M | 20.64% | NEW | — | $19.56 | -15.4% |
| 3 | SION | Sionna Therapeutics, Inc. | Healthcare | 2,995,602.0 | $123.2M | 14.24% | NEW | — | $41.14 | -4.6% |
| 4 | — | Disc Medicine, Inc. | — | 1,513,875.0 | $120.2M | 13.89% | NEW | — | $79.41 | — |
| 5 | DAWN | Day One Biopharmaceuticals, Inc. | Healthcare | 6,412,560.0 | $59.8M | 6.91% | NEW | — | $9.32 | +131.0% |
| 6 | KRRO | Korro Bio, Inc. | Healthcare | 1,137,149.0 | $9.1M | 1.05% | NEW | — | $8.01 | +14.2% |
| 7 | QTTB | Q32 Bio, Inc. | Healthcare | 2,092,106.0 | $6.9M | 0.80% | NEW | — | $3.32 | +82.8% |
| 8 | — | Generation Bio, Co. | — | 827,946.0 | $4.7M | 0.54% | NEW | — | $5.68 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%